Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

NCT04191486 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: T-817MA
DRUG: Placebo

Sponsor

FUJIFILM Toyama Chemical Co., Ltd.